Skip to Content

ER 4 2.25 (Pramipexole dihydrochloride extended-release 2.25 mg)

Pill with imprint ER 4 2.25 is White, Elliptical / Oval and has been identified as Pramipexole dihydrochloride extended-release 2.25 mg. It is supplied by Macleods Pharmaceuticals Limited.

Pramipexole is used in the treatment of restless legs syndrome; parkinson's disease; periodic limb movement disorder; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 2.25 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for ER 4 2.25

Pramipexole dihydrochloride extended-release

Imprint:
ER 4 2.25
Strength:
2.25 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Macleods Pharmaceuticals Limited
National Drug Code (NDC):
33342-0211

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide